{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-07T02:32:40.317232+00:00","company":{"ticker":"ACH","cik":75252,"company_name":"ACCENDRA HEALTH INC/VA/"},"pagination":{"limit":100,"returned":20,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"material_agreement","fact_key":"ca3fc50bfb71e97efc7aedd2ca58bb5277f7a09a","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2026-05-11T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Commitment and Consent Letter","agreement_type":"credit_facility","counterparty":"certain institutions that are holders of the 4.500% Senior Notes due 2029 and 6.625% Senior Notes due 2030, lenders under the Term Loan Credit Agreement, and lenders under the Existing Revolving Credit Facility Agreement","effective_date":"2026-05-11","item_codes_triggered":["1.01"],"value_text":null},"claim":"ACCENDRA HEALTH INC/VA/ entered into Commitment and Consent Letter with certain institutions that are holders of the 4.500% Senior Notes due 2029 and 6.625% Senior Notes due 2030, lenders under the Term Loan Credit Agreement, and lenders under the Existing Revolving Credit Facility Agreement (effective 2026-05-11).","evidence_excerpt":"On May 11, 2026, Accendra Health, Inc. (the “ Company ”) entered into a Commitment and Consent Letter (the “ Commitment Letter ”) with certain institutions that are (a)(i) holders of the Company’s 4.500% Senior Notes due 2029 (the “ 2029 Notes ”) and 6.625% Senior Notes due 2030 (the “ 2030 Notes ” and, together with the 2029 Notes, the “ Existing Notes ”), collectively holding approximately all of the outstanding principal amount of the 2029 Notes and approximately 83% of the outstanding principal amount of the 2030 Notes as of May 11, 2026 and (ii) lenders under the Company’s existing Term Loan Credit Agreement (as defined below) (collectively, the “ Commitment and Consenting Parties ” and each, a “ Commitment and Consenting Party ”), (b) certain lenders under the Company’s existing Term Loan Credit Agreement consenting solely with respect to the Term B-1 Term Loan Consent (as defined below) (the “ Term B-1 Term Loan Consenting Parties ”) and (c) all lenders under the Company’s Exist","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-215654","anchor_url":"https://secwatch.observer/filing/0001193125-26-215654#claim-ca3fc50bfb71e97efc7aedd2ca58bb5277f7a09a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000119312526215654/0001193125-26-215654-index.htm"},{"fact_type":"earnings_release","fact_key":"86693822b1d58181339323e6c678a023f0a447bf","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2026-05-11T23:59:59+00:00","payload":{"eps_text":"$ (0.08)","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$ (6.5)","period_text":"the first quarter ended March 31, 2026","report_date":"2026-05-11","result_type":"reported_results","revenue_text":"$ 627.8"},"claim":"ACCENDRA HEALTH INC/VA/ reported the first quarter ended March 31, 2026 results: revenue $ 627.8, net income $ (6.5), EPS $ (0.08).","evidence_excerpt":"Commission this morning. ​ Details on First Quarter 2026 Results ​ ​ First Quarter Results (1) ​ ($ in millions, except per share data) ​ ​ ​ 1Q26 ​ ​ ​ 1Q25 Net Revenue ​ $ 627.8 ​ $ 673.9 ​ ​ ​ ​ ​ ​ ​ Loss from continuing operations, net of tax, GAAP ​ $ (6.5) ​ $ (3.8) Adj. net (loss) income from continuing operations, Non-GAAP ​ $ (3.1) ​ $ 23.2 ​ ​ ​","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-26-058226","anchor_url":"https://secwatch.observer/filing/0001104659-26-058226#claim-86693822b1d58181339323e6c678a023f0a447bf","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000110465926058226/0001104659-26-058226-index.htm"},{"fact_type":"governance_change","fact_key":"fd1fbf467425639e6da48426e40a177453c0c053","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2025-12-31T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-12-24","item_codes_triggered":["5.03"],"summary_text":"Filed articles of amendment to certificate of incorporation to change corporate name."},"claim":"ACCENDRA HEALTH INC/VA/: Filed articles of amendment to certificate of incorporation to change corporate name (effective 2025-12-24).","evidence_excerpt":"On December 24, 2025, the Company filed articles of amendment to its certificate of incorporation (the “ Articles of Amendment ”) and amended its bylaws (the “ Second Amended and Restated Bylaws ”) to change the corporate name set forth therein from “Owens & Minor, Inc.” to “Accendra Health, Inc.”","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-25-338325","anchor_url":"https://secwatch.observer/filing/0001193125-25-338325#claim-fd1fbf467425639e6da48426e40a177453c0c053","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000119312525338325/0001193125-25-338325-index.htm"},{"fact_type":"governance_change","fact_key":"356d4164270f78e341dd09ebc05177eb4f17ebe2","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2025-12-31T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2025-12-24","item_codes_triggered":["5.03"],"summary_text":"Amended bylaws to change corporate name from Owens & Minor, Inc. to Accendra Health, Inc."},"claim":"ACCENDRA HEALTH INC/VA/: Amended bylaws to change corporate name from Owens & Minor, Inc. to Accendra Health, Inc (effective 2025-12-24).","evidence_excerpt":"On December 24, 2025, the Company filed articles of amendment to its certificate of incorporation (the “ Articles of Amendment ”) and amended its bylaws (the “ Second Amended and Restated Bylaws ”) to change the corporate name set forth therein from “Owens & Minor, Inc.” to “Accendra Health, Inc.”","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-25-338325","anchor_url":"https://secwatch.observer/filing/0001193125-25-338325#claim-356d4164270f78e341dd09ebc05177eb4f17ebe2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000119312525338325/0001193125-25-338325-index.htm"},{"fact_type":"material_agreement","fact_key":"ce2f9b1abdce61b05cfc401bb4232799d0a63fe3","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2025-12-31T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Amended & Restated Receivables Purchase Agreement","agreement_type":"credit_facility","counterparty":"PNC Bank, National Association, PNC Capital Markets LLC","effective_date":null,"item_codes_triggered":["1.01"],"value_text":"$150 million"},"claim":"ACCENDRA HEALTH INC/VA/ amended Amended & Restated Receivables Purchase Agreement with PNC Bank, National Association, PNC Capital Markets LLC valued at $150 million.","evidence_excerpt":"On the Closing Date, O&M Funding LLC (“ O&M Funding ”), as Seller, and Byram Healthcare Centers, Inc. (“ Byram ”), as initial Servicer, each a wholly-owned subsidiary of the Company, entered into an Amended & Restated Receivables Purchase Agreement (the “ Amended & Restated Receivables Purchase Agreement ”) with persons from time to time party thereto, as Purchasers, PNC Bank, National Association (“ PNC ”), as Administrative Agent, and PNC Capital Markets LLC, as Structuring Agent, pursuant to which accounts receivable with an aggregate outstanding amount not to exceed $150 million are sold","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-25-338325","anchor_url":"https://secwatch.observer/filing/0001193125-25-338325#claim-ce2f9b1abdce61b05cfc401bb4232799d0a63fe3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000119312525338325/0001193125-25-338325-index.htm"},{"fact_type":"debt_financing","fact_key":"ddc0ad8b27e20dfe478b8a1260c7c17cd2846217","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2025-12-31T23:59:59+00:00","payload":{"counterparty":"PNC Bank, National Association","effective_date":"2025-12-31","event":"incurrence","instrument_type":"other","interest_rate_text":null,"item_codes_triggered":["2.03"],"maturity_text":"Scheduled Termination Date of October 18, 2027","principal_text":"aggregate outstanding amount not to exceed $150 million"},"claim":"ACCENDRA HEALTH INC/VA/ incurred debt of aggregate outstanding amount not to exceed $150 million with PNC Bank, National Association maturing Scheduled Termination Date of October 18, 2027.","evidence_excerpt":"On the Closing Date, O&M Funding LLC (“ O&M Funding ”), as Seller, and Byram Healthcare Centers, Inc. (“ Byram ”), as initial Servicer, each a wholly-owned subsidiary of the Company, entered into an Amended & Restated Receivables Purchase Agreement (the “ Amended & Restated Receivables Purchase Agreement ”) with persons from time to time party thereto, as Purchasers, PNC Bank, National Association (“ PNC ”), as Administrative Agent, and PNC Capital Markets LLC, as Structuring Agent, pursuant to which accounts receivable with an aggregate outstanding amount not to exceed $150 million are sold, on a limited-recourse basis, to the Purchasers in exchange for cash (the “ Receivables Sale Program ”).","confidence":0.85,"filing_url":"https://secwatch.observer/filing/0001193125-25-338325","anchor_url":"https://secwatch.observer/filing/0001193125-25-338325#claim-ddc0ad8b27e20dfe478b8a1260c7c17cd2846217","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000119312525338325/0001193125-25-338325-index.htm"},{"fact_type":"ma_transaction","fact_key":"49b5a03abce95fef648ce94e71e7dcbaa6665515","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2025-12-31T23:59:59+00:00","payload":{"action":"disposition","closing_date":"2025-12-31","consideration_text":"$375 million in cash","counterparty":"Dominion Healthcare Acquisition Corporation and Dominion Healthcare Holdings, L.P.","effective_date":"2025-12-31","item_codes_triggered":["2.01"]},"claim":"ACCENDRA HEALTH INC/VA/ completed a disposition involving Dominion Healthcare Acquisition Corporation and Dominion Healthcare Holdings, L.P. for $375 million in cash (closed 2025-12-31).","evidence_excerpt":"effect to the completion of certain reorganization transactions, comprises the “ Products & Healthcare Services ” or “ P&HS ” business of the Company), for an aggregate of $375 million in cash, subject to certain adjustments for cash, indebtedness, net working capital and transaction expenses (the “ Sale ”) and (ii) contributed, assigned, transferred and","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-25-338325","anchor_url":"https://secwatch.observer/filing/0001193125-25-338325#claim-49b5a03abce95fef648ce94e71e7dcbaa6665515","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000119312525338325/0001193125-25-338325-index.htm"},{"fact_type":"debt_financing","fact_key":"a220b40fccb7880171336b6f97dcfa3683039d00","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2025-06-06T23:59:59+00:00","payload":{"counterparty":"Regions Bank","effective_date":"2025-06-05","event":"acceleration","instrument_type":"senior_notes","interest_rate_text":"10.000%","item_codes_triggered":["2.04"],"maturity_text":"due 2030","principal_text":"$1,000,000,000 aggregate principal amount"},"claim":"ACCENDRA HEALTH INC/VA/ faced acceleration on senior notes of $1,000,000,000 aggregate principal amount with Regions Bank at 10.000% maturing due 2030.","evidence_excerpt":"of April 4, 2025, by and among the Company, the guarantors named therein and Regions Bank, as trustee and as collateral agent (the “Indenture”), under which the Company issued $1,000,000,000 aggregate principal amount of 10.000% Senior Secured Notes due 2030 (the “Notes”), the Company is required to redeem such Notes. On June 5, 2025, the Company issued a notice of","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-25-137107","anchor_url":"https://secwatch.observer/filing/0001193125-25-137107#claim-a220b40fccb7880171336b6f97dcfa3683039d00","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000119312525137107/0001193125-25-137107-index.htm"},{"fact_type":"executive_change","fact_key":"73d1ed94d9","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2024-09-23T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-09-23","interim":false,"role":"Executive Vice President, Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Jonathan A. Leon was appointed as Executive Vice President, Chief Financial Officer at ACCENDRA HEALTH INC/VA/.","evidence_excerpt":"On September 23, 2024, Owens & Minor, Inc. (the “Company”) announced that Jonathan A. Leon, age 58, has been appointed Executive Vice President, Chief Financial Officer of the Company, effective September 23, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-223254","anchor_url":"https://secwatch.observer/filing/0001193125-24-223254#claim-73d1ed94d9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000119312524223254/0001193125-24-223254-index.htm"},{"fact_type":"executive_change","fact_key":"f60779b912","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2024-06-24T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-06-21","interim":true,"role":"Interim Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Jonathan A. Leon was appointed as Interim Chief Financial Officer at ACCENDRA HEALTH INC/VA/.","evidence_excerpt":"Jonathan A. Leon, the Company’s Senior Vice President, Corporate Treasurer, has been appointed as interim Chief Financial Officer effective June 21, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-166962","anchor_url":"https://secwatch.observer/filing/0001193125-24-166962#claim-f60779b912","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000119312524166962/0001193125-24-166962-index.htm"},{"fact_type":"executive_change","fact_key":"e4914006f9","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2024-06-24T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"abrupt","effective_date":"2024-06-21","interim":false,"role":"Executive Vice President & Chief Financial Officer","role_category":"cfo","successor_name":"Jonathan A. Leon","successor_named":true},"claim":"Alexander J. Bruni resigned as Executive Vice President & Chief Financial Officer at ACCENDRA HEALTH INC/VA/.","evidence_excerpt":"Alexander J. Bruni, the Company’s Executive Vice President & Chief Financial Officer, has, at the request of the Company, resigned from his position as an officer of the Company, effective June 21, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-166962","anchor_url":"https://secwatch.observer/filing/0001193125-24-166962#claim-e4914006f9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000119312524166962/0001193125-24-166962-index.htm"},{"fact_type":"executive_change","fact_key":"a8a260ab47","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2024-05-24T23:59:59+00:00","payload":{"action":"named","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-06-03","interim":false,"role":"Executive Vice President & Chief Human Resources Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Jennifer Stone was named as Executive Vice President & Chief Human Resources Officer at ACCENDRA HEALTH INC/VA/.","evidence_excerpt":"On May 24, 2024, Owens & Minor, Inc. (the Company) named Jennifer Stone (53) Executive Vice President & Chief Human Resources Officer of the Company effective June 3, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001558370-24-008643","anchor_url":"https://secwatch.observer/filing/0001558370-24-008643#claim-a8a260ab47","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000155837024008643/0001558370-24-008643-index.htm"},{"fact_type":"shareholder_vote","fact_key":"16004aad9a3ef478d4d9fc50aafe7fb62cc9d4fe","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2024-05-10T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-09","outcome":"passed","proposal_text":"Advisory vote to approve the compensation of our named executive officers","proposal_type":"say_on_pay","votes_abstain_text":"60,198","votes_against_text":"1,381,531","votes_for_text":"66,163,767"},"claim":"ACCENDRA HEALTH INC/VA/ shareholders approved Advisory vote to approve the compensation of our named executive officers at the 2024-05-09 meeting.","evidence_excerpt":"2023 Omnibus Incentive Plan, as follows: ​ Votes ​ Votes For Votes Against Abstentions Broker Non- Votes 64,181,423 3,371,256 52,817 3,113,777 ​ (4) Advisory vote to approve the compensation of our named executive officers as follows: ​ Votes ​ Votes For Votes Against Abstentions Broker Non- Votes 66,163,767 1,381,531 60,198 3,113,777 ​ ​ ​ ​ ​ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001558370-24-007697","anchor_url":"https://secwatch.observer/filing/0001558370-24-007697#claim-16004aad9a3ef478d4d9fc50aafe7fb62cc9d4fe","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000155837024007697/0001558370-24-007697-index.htm"},{"fact_type":"shareholder_vote","fact_key":"cc56450c7b78d4bd289d292f95b60a74b7146216","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2024-05-10T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-09","outcome":"passed","proposal_text":"Approval of Amendment No. 1 to the Owens & Minor, Inc. 2023 Omnibus Incentive Plan","proposal_type":"equity_plan","votes_abstain_text":"52,817","votes_against_text":"3,371,256","votes_for_text":"64,181,423"},"claim":"ACCENDRA HEALTH INC/VA/ shareholders approved Approval of Amendment No. 1 to the Owens & Minor, Inc. 2023 Omnibus Incentive Plan at the 2024-05-09 meeting.","evidence_excerpt":"(3) Approval of Amendment No. 1 to the Owens & Minor, Inc. 2023 Omnibus Incentive Plan","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001558370-24-007697","anchor_url":"https://secwatch.observer/filing/0001558370-24-007697#claim-cc56450c7b78d4bd289d292f95b60a74b7146216","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000155837024007697/0001558370-24-007697-index.htm"},{"fact_type":"shareholder_vote","fact_key":"3c78d86b3b27eb1584ac3c57b098b230a4591acc","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2024-05-10T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-09","outcome":"passed","proposal_text":"Ratification of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024","proposal_type":"auditor_ratification","votes_abstain_text":"40,025","votes_against_text":"1,471,594","votes_for_text":"69,207,654"},"claim":"ACCENDRA HEALTH INC/VA/ shareholders approved Ratification of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 at the 2024-05-09 meeting.","evidence_excerpt":"(2) Ratification of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001558370-24-007697","anchor_url":"https://secwatch.observer/filing/0001558370-24-007697#claim-3c78d86b3b27eb1584ac3c57b098b230a4591acc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000155837024007697/0001558370-24-007697-index.htm"},{"fact_type":"shareholder_vote","fact_key":"9577f432455fcf8857a6e85360c01092f7ab20db","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2024-05-10T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-09","outcome":"passed","proposal_text":"Election of nine directors, each for a one-year term","proposal_type":"director_election","votes_abstain_text":"See individual nominees above","votes_against_text":"See individual nominees above","votes_for_text":"See individual nominees above"},"claim":"ACCENDRA HEALTH INC/VA/ shareholders approved Election of nine directors, each for a one-year term at the 2024-05-09 meeting.","evidence_excerpt":"​ (1) Election of nine directors, each for a one-year term, as follows: ​ Director Votes For Votes Against Abstentions Broker Non- Votes Mark A.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001558370-24-007697","anchor_url":"https://secwatch.observer/filing/0001558370-24-007697#claim-9577f432455fcf8857a6e85360c01092f7ab20db","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000155837024007697/0001558370-24-007697-index.htm"},{"fact_type":"executive_change","fact_key":"9eda201e76","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2024-05-09T23:59:59+00:00","payload":{"action":"named","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2024-05-09","interim":false,"role":"Executive Vice President & Chief Information Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Snehashish Sarkar was named as Executive Vice President & Chief Information Officer at ACCENDRA HEALTH INC/VA/.","evidence_excerpt":"On May 9, 2024 Owens & Minor, Inc. (the Company) named Snehashish Sarkar (49) Executive Vice President & Chief Information Officer of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001558370-24-007615","anchor_url":"https://secwatch.observer/filing/0001558370-24-007615#claim-9eda201e76","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000155837024007615/0001558370-24-007615-index.htm"},{"fact_type":"earnings_release","fact_key":"e3cce95d9fabe3c97fa3e000ee4bb4f37efe5b5b","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2024-05-03T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$(0.29) per share","period_text":"the first quarter ended March 31, 2024","report_date":"2024-05-03","result_type":"reported_results","revenue_text":"$2.6 billion"},"claim":"ACCENDRA HEALTH INC/VA/ reported the first quarter ended March 31, 2024 results: revenue $2.6 billion, net income $(0.29) per share.","evidence_excerpt":"VA – May 3, 2024 – Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the first quarter ended March 31, 2024. ​ Key Highlights: ● Consolidated revenue of $2.6 billion in the first quarter, representing year-over-year growth of 4% ● GAAP operating margin was flat while adjusted operating margin expanded by 31 basis points versus prior year ●","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001558370-24-006589","anchor_url":"https://secwatch.observer/filing/0001558370-24-006589#claim-e3cce95d9fabe3c97fa3e000ee4bb4f37efe5b5b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000155837024006589/0001558370-24-006589-index.htm"},{"fact_type":"executive_change","fact_key":"7ccc783244","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2024-04-22T23:59:59+00:00","payload":{"action":"retired","action_category":"departure","departure_tone":"retirement","effective_date":"2024-05-17","interim":false,"role":"Executive Vice President, Business Excellence","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Dan J. Starck retired as Executive Vice President, Business Excellence at ACCENDRA HEALTH INC/VA/.","evidence_excerpt":"On April 16, 2024, Dan J. Starck, Executive Vice President, Business Excellence of Owens & Minor, Inc. (the “Company”), informed the Company that he was retiring from his position at the Company, effective May 17, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-103827","anchor_url":"https://secwatch.observer/filing/0001193125-24-103827#claim-7ccc783244","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000119312524103827/0001193125-24-103827-index.htm"},{"fact_type":"earnings_release","fact_key":"26089f518528e6c3de2721794ed65c9cb531e7eb","cik":75252,"ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2024-02-20T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"Net loss per common share of $(0.54) and adjusted net income per common share of $1.36","period_text":"the fourth quarter and year ended December 31, 2023","report_date":"2024-02-20","result_type":"reported_results","revenue_text":"$10.3 billion"},"claim":"ACCENDRA HEALTH INC/VA/ reported the fourth quarter and year ended December 31, 2023 results: revenue $10.3 billion, net income Net loss per common share of $(0.54) and adjusted net income per common share of $1.36.","evidence_excerpt":"& Minor, Inc. (NYSE: OMI) today reported financial results for the fourth quarter and year ended December 31, 2023. ​ Full Year 2023 Key Highlights: ● Consolidated revenue of $10.3 billion ● Delivered $741 million of operating cash flow ● Reduced total debt by $403 million and reduced net debt by $577 million ● Net loss per common share of $(0.54) and adjusted net","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001558370-24-001321","anchor_url":"https://secwatch.observer/filing/0001558370-24-001321#claim-26089f518528e6c3de2721794ed65c9cb531e7eb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/75252/000155837024001321/0001558370-24-001321-index.htm"}]}